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Abstract 
 The acetylation/deacetylation of Lys40 of the α-subunit is an important post-translational 
modification undergone by tubulin during the life of a cell. Many previous studies have addressed 
the physiological role of this acetylation process using various approaches based on changes of 
acetylated tubulin (AcTubulin) content. In most of these studies, however, the actual amounts of 
AcTubulin were not known and it was difficult to draw conclusions. We present here a simple 
method to estimate the percentage of AcTubulin relative to total tubulin. The method is based on 
acetylation of the tubulin sample with acetic anhydride, Western blotting stained by anti-AcTubulin 
antibody, and comparison of the optical density of the AcTubulin band with that of a corresponding 
sample that was not chemically acetylated. 
 
Key words: acetylated tubulin, microtubules, quantification method, chemical acetylation 
 
  
 
Introduction 
 Microtubules are dynamic fibrous structures present in the cytoplasm of all eukaryotic cells. 
The main constituent protein of microtubules, tubulin, is subject to many post-translational 
modifications including acetylation/deacetylation, tyrosination/detyrosination, polyglutamylation, 
polyglycylation, and phosphorylation [Janke and Bulinski, 2011]. The functional roles of these 
tubulin modifications have not been precisely defined in spite of intensive studies. It is increasingly 
clear that acetylation of tubulin plays an important role in various cell functions including cell 
migration, division, and differentiation [Perdiz et al., 2011], although conflicting results have been 
obtained in some studies. Our previous studies have shown that acetylated tubulin (AcTubulin)is 
specifically associated with Na+,K+-ATPase (the sodium pump) in membranes of neural and non-
neural cells and that this association results in inhibition of the ATPase activity [Alonso et al., 1998; 
Casale et al., 2001; Casale et al., 2003; Casale et al., 2005; Santander et al., 2006; Zampar et al., 
2009]. Specific acetylation catalyzed by MEC-17 occurs on the ε-NH2 group of Lys40 of the α-
tubulin chain [Akella et al., 2010; Shida et al., 2010], and the acetyl group can be removed by 
NAD-dependent Sirtuin2 (Sirt2, an analog of yeast Sir2) [North et al., 2003] and by cytoplasmic 
histone deacetylase 6 (HDAC6) [Hubbert et al., 2002; Zhang et al., 2003]. The acetyl group can 
also be added to Lys40(and to other reactive amino acid residues of tubulin and of contaminant 
proteins) by chemical acetylation with acetic anhydride [Piperno and Fuller, 1985]. To avoid 
nomenclatural confusion, we use the term “AcTubulin” in this paper to refer to tubulin that contains 
an acetyl group bound to the ε-NH2 of Lys40 of the α-chain and “chemically acetylated tubulin” to 
refer to tubulin in which acetyl groups are bound nonspecifically to not only Lys40 but also other Lys 
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residues and other sites that can be acetylated. The monoclonal antibody (mAb) 6-11B-1 is 
specific to the acetylatedLys40 of α-tubulin [Piperno and Fuller, 1985] and can therefore be used to 
distinguish this epitope from all acetyl groups bound to other sites on α-tubulin as a result of 
chemical acetylation. In most published studies regarding the role of tubulin acetylation, 
conclusions have been drawn on the basis of cell behavior following an increase or decrease in the 
amount of AcTubulin in cultured cells by inhibiting/silencing or overexpressing the acetylating or 
deacetylating enzymes [Hubbert et al., 2002; Li et al., 2012; Tran et al., 2007]. The amount of 
AcTubulin in cultured cells is generally very low. Even when treatment with Sirt2 or HDAC6 
inhibitors produces a seemingly large increase of AcTubulin as visualized by immunofluorescence 
microscopy or Western blotting, the resulting amounts of AcTubulin relative to total tubulin are 
uncertain. In most biochemical experiments using partially purified tubulin, the investigators have 
not taken into account the proportion of tubulin molecules that are acetylated on Lys40 of α-tubulin 
with respect to total tubulin. We must therefore be cautious in drawing conclusions from this type of 
experiment. Data regarding the amount of AcTubulin in each experimental system are essential for 
designing protocols and for drawing reliable conclusions. Conclusions or assumptions from cellular 
and molecular experiments should be corroborated using biochemical systems with purified 
proteins. We recently described a method for purifying tubulin with a high acetylated isotype 
content from rat brain and determined that approximately 64% of such tubulin molecules are 
acetylated [Carbajal et al., 2013]. We now describe a simple method to estimate the amount of 
AcTubulin as a percentage of total tubulin. This method can be used to quantify AcTubulin in 
purified tubulin preparations or in crude extracts from cells. 
 
 
Materials and Methods 
 
Chemicals 
 MES (2-(N-morpholino)ethanesulfonic acid), TSA (Trichostatin A), Taxol, Triton X-100, BSA 
(bovine serum albumin), SDS, EGTA, PMSF, phenanthroline, mouse mAb 6-11B-1 specific for 
AcTubulin, culture media and antibiotics were from Sigma-Aldrich (St. Louis, MO, USA). IRDye 
800CW goat anti-mouse IgG was from Li-Cor Biosciences (Lincoln, NE, USA). Recombinant 
Protein G-Sepharose 4B conjugate was from Invitrogen Corp. (Grand Island, NY, USA) and Alexa 
Fluor® 488 Donkey Anti-Mouse IgG (H+L) was from Santa Cruz Biotechnology Inc. (Santa Cruz, 
CA, USA). FluorSave reagent was from Calbiochem/ EMD Biosciences (La Jolla, CA, USA). Fetal 
bovine serum was from Natocor (Córdoba, Argentina). Boric acid was from PlusOne, Pharmacia 
Biotech (Uppsala, Sweden). Acetic anhydride was from J. T. Baker (Phillipsburg, NJ, USA).
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Cells 
 CAD cells (a subclone of a catecholaminergic cell line derived from a mouse neuronal brain 
tumor) were cultured in DMEM/F12 (Dulbecco’s modified Eagle’s medium/Ham’s F12). CHO 
(Chinese Hamster Ovary) and COS cells were grown in DMEM.  All cell lines were cultured in their 
respective media supplemented with 10 % (v/v) FBS, 10 units/ml penicillin, and 100 µg/ml 
streptomycin and maintained at 37 ºC in an air/CO2 (19:1) atmosphere with high humidity. 
 
Purification of microtubule protein depleted or enriched in AcTubulin 
 Purification of two tubulin preparations was performed as described previously [Carbajal et al., 
2013]. The same protocol was used for purification of tubulin depleted or enriched in the acetylated 
isotype except that TSA, an HDAC6 inhibitor, was added to the buffers for the AcTubulin-enriched 
preparation and absent for the AcTubulin-depleted preparation. Briefly, Wistar rat brains were 
homogenized in 1.5 volumes of cold (0 ºC) MEM buffer (100 mM MES buffer, pH 6.7, containing 1 
mM EGTA, 1 mM MgCl2, 1 mM PMSF, and 1 mM phenanthroline) supplemented with 5 µM TSA 
for the AcTubulin-enriched preparation and centrifuged at 100,000 x g for 30 min at 4 ºC. The 
supernatant fraction (termed SN1) was added with glycerol (final concentration 40%) and incubated 
at 37 ºC for 30 min. The mixture was centrifuged at 100,000 x g for 30 min at 27 ºC, and the 
supernatant (SN2) and sedimented microtubules (P2) were separated. The microtubules were 
resuspended in cold MEM buffer (1/5 of the original volume) containing 1µM TSA for the 
AcTubulin-enriched preparation, kept at 0 ºC for 30 min, and centrifuged at 100,000 x g for 30 min 
at 4 ºC. The supernatant (SN3; microtubule protein purified by one cycle) was collected. 
 Animal handling was performed according to the Guide to the Care and Use of Experimental 
Animals published by the Canadian Council on Animal Care and approved by the local animal care 
committee (Faculty of Chemistry, Universidad Nacional de Córdoba, Argentina). 
 
Immunopurification of AcTubulin 
 Anti-AcTubulin mAb 6-11B-1 was linked to Protein G-Sepharose beads (100 µg IgG: 200 µl 
beads) following the manufacturer's instructions. The 6-11B-1-linked beads were mixed with 600 µl 
(1.5 mg/ml) of an AcTubulin-enriched preparation (SN3), incubated for 2 h at room temperature and 
washed 5 times with 10 bed volumes of PBS supplemented with 0.5% Triton X-100. Bound 
proteins were eluted twice by mild agitation for 5 min at room temperature with 400 µl of 100 mM 
sodium carbonate buffer, pH 12, containing 9 µM TSA. The two eluted fractions were combined 
and stored at -20 °C. As a control, 6-11B-1-linked beads were incubated with an AcTubulin-
depleted preparation and processed in the same way. 
 
SDS-PAGE and Western blotting 
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 Proteins were separated by SDS-PAGE (10% gels) [Laemmli, 1970] and transferred to 
nitrocellulose sheets [Towbin et al., 1979]. The sheets were incubated with primary antibody for 4 h 
at room temperature (anti-AcTubulin: 1:5,000 dilution; 1% non-fat milk in PBS as blocking 
medium), washed, incubated with infrared fluorescent secondary antibody for 1 h at room 
temperature (1:25,000 dilution; blocking medium as above), washed, and scanned by an Odyssey 
infrared scanner (Li-Cor). Bands were quantified using the Scion Image software program (Scion 
Corporation; Frederick, Maryland, USA). 
 
Immunofluorescence 
 Cells were cultured on coverslips and fixed with anhydrous methanol at -20 ºC for 10 min. The 
samples were washed with PBS, incubated with 5% (w/v) BSA in PBS for 1 h, and incubated with 
the primary antibody (anti-AcTubulin mAb 6-11-B1, 1:1,000 dilution; 1% BSA in PBS as blocking 
medium) for 4 h at 37ºC. The cells were washed 3 times with PBS, incubated for 1 h at 37ºC 
with secondary antibody (anti-mouse IgG-Alexa488 diluted 1:1000), washed 3 times with PBS, and 
the coverslips were mounted in FluorSave reagent. Images were collected using an FV1000 
Olympus confocal spectral microscope (Olympus Latin America, Miami, FL, USA) equipped with an 
argon/helium/neon laser at the appropriate wavelength and the software (Olympus FV Viewer) 
provided by the manufacturer, and processed using the Image J program 1.46r (Wayne Rasband; 
NIH, USA).
 
Chemical acetylation of tubulin 
 Partially purified preparations:A 100-µl sample of SN1 (15 mg/ml protein) or of a microtubule 
protein preparation purified by one cycle (2-4 mg/ml protein) was mixed with 125 µl of boric acid 
(500 mM, pH 9) and then with 50 µl of 1% (v/v) freshly prepared cold acetic anhydride. After 
incubation at 4 ºC for 20 min, 100 µl of 5x Laemmli sample buffer was added. The samples were 
diluted with 1x Laemmli sample buffer to obtain tubulin concentrations adequate for SDS-PAGE 
and Western blotting. Two samples (containing 1x and 2x tubulin amounts) of each sample were 
electrophoresed in triplicate. A control (non-acetylated) sample in which acetic anhydride was 
substituted by distilled water was processed in parallel. 
 Cell extracts: Cells from a 10-cm diameter culture dish (80% confluence) were washed with 10 
ml of warm (37 °C) PBS and harvested in 2 ml of ext raction buffer (280 mM boric acid, pH 9, 1% 
SDS, 3 µM TSA, 1 mM PMSF, and 1 mM EGTA). The cell extract was sonicated 3 times for 30 sec 
at position 40 in a Cole Parmer Ultrasonic Homogenizer and centrifuged at 10,000 x g for 10 min at 
15 °C. The supernatant fraction was collected and d ivided into 2 fractions of 900 µl each. One 
fraction was added with 110 µl of water and the other with 110 µl of 2% (v/v) freshly prepared 
acetic anhydride. Both aliquots were kept at 4 °C f or 20 min and then subjected to protein 
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precipitation with methanol-chloroform (see following section). Protein pellets were resuspended in 
300 µl of Laemmli sample buffer with 5% 2-mercaptoethanol and sonicated 3 times for 30 sec. 
Aliquots (approximately 20 µl) of each preparation were subjected (in triplicate) to Western blotting 
with mAb 6-11B-1 to analyze AcTubulin. 
 
Methanol-chloroform protein precipitation 
 The method of Wessel and Flügge [1984] was used. Briefly, 1 volume of aqueous protein 
solution was mixed with 1.25 volumes of methanol-chloroform (4:1) by vortexing for approximately 
30 sec. The mixture was centrifuged at 10,000 x g for 10 min at room temperature, and the upper 
phase was carefully removed without removing the interphase. Methanol (0.75 volumes relative to 
the original volume) was added, and the mixture was centrifuged at 10,000 x g at room 
temperature for 10 min. The solvent was removed, and the pellet was dried at room temperature 
and then resuspended in Laemmli sample buffer and sonicated. 
 
Protein measurement 
 Protein content was measured by the method of Bradford (1976) using bovine serum albumin 
as the standard. 
 
 
Results and Discussion 
 
The basic concept of the method 
 The method described here is based on the increase in the amount ofAcTubulin produced by 
chemical acetylation of a tubulin sample relative to that of an identical amount of non-treated 
sample, assuming that Lys40 of α-tubulin is 100% acetylated by the procedure. A sample of the 
tubulin preparation to be analyzed is extensively acetylated with acetic anhydride in a one-step 
procedure and then subjected to Western blotting and staining with specific anti-AcTubulin mAb 6-
11B-1("chemically acetylated"). A sample containing an identical amount of protein is processed in 
the same way but with substitution of acetic anhydride by vehicle ("non-chemically acetylated"). It 
should be noted that the non-chemically acetylated sample may contain a certain amount of 
endogenous acetylated tubulin. The optical densities (O.D.) of the AcTubulin bands are 
determined. The percentage of AcTubulin relative to total tubulin is calculated by the following 
formula: 
 
% AcTubulin = (O.D. non-chemically acetylated / O.D. chemically acetylated) x 100% 
 
Page 6 of 18
John Wiley & Sons
Cytoskeleton


 This formula is applicable provided that: (i) the optical density valuesare directly proportional to 
the protein amounts; (ii) identical amounts of total tubulin in the "acetylated” and “non-acetylated" 
samples are compared. To satisfy these criteria, identical volumes of the two samples must be 
processed in parallel. 
 
Conditions for maximal tubulin acetylation on Lys40 of the α-subunit 
 Chemical acetylation of a crude rat brain preparation (SN1, obtained in the absence of TSA) 
resulted in a large increase of AcTubulin as assessed by Western blotting with specific mAb 6-11B-
1 (Fig. 1A). A slight decrease in the electrophoretic mobility of the chemically acetylated tubulin 
band was observed. This decrease may have resulted from an alteration in the molecular weight 
and/or spatial structure of the tubulin molecule and/or in the affinity for SDS induced by acetylation 
of protein sites other than Lys40 of α-tubulin. The effect of chemical acetylation on an AcTubulin 
preparation considered to be 100% acetylated because it was immunopurified from an AcTubulin-
enriched preparation is shown in Fig. 1A (right panel). A similar shift in the electrophoretic mobility 
was more clearly observed. Chemical acetylation did not significantly increase the intensity of the 
immunopurified tubulin sample. This finding suggests that chemical acetylation does not 
significantly interfere with the affinity of mAb 6-11B-1. The fact that in both cases (with SN1 and 
with immunopurified tubulin) the shift in electrophoretic mobility affected most (perhaps all) of the 
tubulin molecules suggests that the acetylation was complete. To confirm that a single acetylation 
step was sufficient to acetylate 100% of Lys40, a SN1 preparation (obtained in the absence of TSA) 
was subjected to chemical acetylation 1, 2, and 3 times. Following the analysis of various amounts 
of protein by Western blotting, no significant increase in AcTubulin content was observed (Fig. 1B) 
when this procedure was repeated once or twice on a tubulin sample that was previously 
chemically acetylated. This finding was confirmed statistically (Fig. 1C). Taken together, these 
results indicate that one cycle of chemical acetylation under the conditions described is sufficient 
for extensive and maximal acetylation of Lys40 of the α-chain of tubulin. 
 Because chemical acetylation is nonspecific, we considered the possibility that the reaction 
generated new epitopes in the tubulin molecule that were recognized by mAb 6-11B-1. However, 
following acetylation of a crude soluble brain extract (SN1) in which more than 84% of the proteins 
were contaminants of tubulin (Fig. 2A), approximately 94% of the 6-11B-1 staining coincided with 
the tubulin band (Fig. 2B) and the remaining 6% with other protein bands, indicating a very low 
probability that chemical acetylation could generate new epitopes recognized by 6-11B-1 in sites 
other than Lys40. This finding is consistent with the observation that chemical acetylation of a 100% 
pure AcTubulin sample did not increase the intensity of the AcTubulin band (Fig. 1A, right panel). 
We conclude that most (perhaps all) of the staining of the tubulin band following chemical 
acetylation was due to the reactivity of the acetyl group on Lys40 of the α-subunit. 
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Factors that might alter the basic concept of the method 
 After chemical acetylation and subsequent SDS-PAGE and staining with Coomassie Blue, we 
observed a lower intensity in the staining that coincided with the tubulin band, in comparison with 
an equivalent aliquot of the non-acetylated sample. This finding was surprising because we loaded 
equal amounts of acetylated and non-acetylated samples. This observation was presumed to 
reflect a staining artifact rather than an actual loss of tubulin because silver staining did not reveal 
such a difference. This conclusion was supported by the finding that after nitrocellulose blotting 
and staining with an anti-Glu-tubulin antibody the optical densities of the two samples were 
identical (results not shown). These are important controls because the method is based on the 
comparison of equal amounts of total tubulin before and after chemical acetylation. We presume 
that the above difference was due to a lower affinity of Coomassie Blue for proteins whose 
structures were altered by the incorporation of acetyl groups in several sites. 
 The determination of the amount of AcTubulin relative to total tubulin is dependent on the 
optical density of the AcTubulin band (as detected using mAb 6-11B-1) before vs. after chemical 
acetylation. It was therefore important to determine whether the optical density values were directly 
proportional to the AcTubulin amounts and to determine the range of linearity. This function was 
linear up to 0.8 µg protein (equivalent to approximately 440 ng AcTubulin because in this 
preparation tubulin accounts for approximately 55% of total protein) (Fig. 3). When this method is 
applied to unknown samples, it is therefore convenient to load various amounts of the samples for 
the corresponding Western blot analysis and to use data collected within the linear range. 
 
Experimental validation of the method 
 To test the accuracy of the method, we prepared 3 tubulin preparations with known AcTubulin 
concentrations and applied the chemical acetylation procedure to determine experimentally the 
AcTubulin concentration in each preparation. The AcTubulin standards were prepared by mixing 
different proportions of an AcTubulin-enriched preparation (SN3, obtained in the presence of TSA) 
that contained 64% AcTubulin with another tubulin preparation (of the same concentration) lacking 
the acetylated isotype [Carbajal et al., 2013]. The 3 AcTubulin standards contained 7.5, 27.5, and 
60% AcTubulin, respectively. The AcTubulin amounts determined by our method were in good 
agreement (within 10% standard error) with the values corresponding to the standards (Fig. 4). The 
method is therefore useful for estimation of the percentage of acetylated tubulin molecules relative 
to total tubulin. 
 
Quantification of AcTubulin in cultured cells 
 The measurement of AcTubulin content in cultured cells using the chemical acetylation 
method requires the use of buffers containing SDS or Triton X-100 to dissolve the cells and, in 
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some cases, to isolate the soluble and cytoskeletal fractions. We examined the effects of these 
detergents on the degree of acetylation obtained by chemical acetylation of a crude soluble rat 
brain preparation (SN1, obtained in the absence of TSA). Various amounts of the detergents were 
mixed with the tubulin preparation, and the mixtures were subjected to chemical acetylation and 
subsequent Western blot analysis and staining with mAb 6-11B-1. No differences in the optical 
densities of tubulin bands were observed among any of the detergent samples or the sample 
without detergent (Fig. 5A). This finding indicates that the SDS or Triton X-100 used to dissolve 
cultured cells did not interfere with our quantification method. We then applied the method to 
estimate the amount of AcTubulin in 3 cell types treated or not with TSA. The AcTubulin content in 
non-treated cells was generally very low (Fig. 5B). The effect of TSA treatment was variable 
depending on the cell type. The AcTubulin content increased approximately 4-fold in CHO cells 
and approximately 20-fold in COS cells. CAD cells showed a very low (or zero) AcTubulin content, 
and this content increased to 25% of total tubulin after TSA treatment. A comparison of 
immunofluorescence images revealed with anti-AcTubulin of similarly treated vs. non-treated cells 
(Fig. 5C) showed a general consistency with Western blot values (Fig. 5B). Taxol is another well-
known compound that induces an increase in the amount of acetylated microtubules in living cells 
because of its microtubule-stabilizing effect. A further experiment showed that the increase of 
AcTubulin in CHO and COS cells induced by taxol after 2 and 6 h of treatment and visualized by 
immunofluorescence microscopy (Fig. 6A), although less than the increase produced by TSA, 
could be detected and quantified by the chemical acetylation method (Fig.6B). 
 These findings indicate that our method is sufficiently sensitive to detect modest variations of 
AcTubulin content in cells. This quantification method, in combination with immunofluorescence 
microscopy, will be useful for further studies of the physiological role of tubulin acetylation. 
Immunofluorescence microscopy is a useful method for revealing the intracellular localization and 
eventual changes of acetylated tubulin, while the quantification method described here is a useful 
complement for measuring the magnitude of the phenomenon. 
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Figure Legends 
 
Fig. 1. Chemical acetylation of tubulin. (A) Two types of tubulin preparation were chemically 
acetylated: a SN1 fraction (obtained in the absence of TSA) and an immunopurified AcTubulin 
preparation (see Materials and Methods). The 2 preparations were chemically acetylated (+) or not 
(-) and subjected to Western blot analysis and staining with anti-AcTubulin mAb 6-11B-1. Following 
chemical acetylation, the AcTubulin band in both cases showed a lower electrophoretic mobility 
(arrow) in comparison with the preparation that was not chemically acetylated (arrowhead). (B) A 
microtubule protein (3 mg/ml) preparation purified by 1 cycle of assembly/disassembly was 
incubated for 20 min at room temperature in the presence of 1% acetic anhydride, pH 9. An aliquot 
was removed for subsequent analysis (Western blotting with mAb 6-11B-1), and the mixture was 
acetylated again under the same conditions. Another aliquot was removed, and a third acetylation 
step was performed. (C) Various protein amounts from each of the 3 acetylation steps as above 
were immunoblotted and stained with mAb 6-11B-1. AcTubulin bands from 3 independent 
experiments were scanned and the optical density values (mean ± S.D.)are shown. 
 
Fig. 2. Immunoreactivity of mAb 6-11B-1 with proteins of a crude brain extract following 
chemical acetylation. The soluble extract of a rat brain homogenate was acetylated with acetic 
anhydride and subjected to SDS-PAGE and immunoblotting with mAb 6-11B-1. (A) Chromatogram 
of the soluble extract stained with Coomassie Blue and the corresponding densitogram showing 
that tubulin (arrowhead) accounts for 16% of total proteins. (B) Immunoblot stained with mAb 6-
11B-1 and the corresponding densitogram. Staining that coincides with the tubulin band accounted 
for 94% of the total immunoreactivity. 
 
Fig. 3. Standard curve for AcTubulin.  An AcTubulin-enriched preparation (microtubule protein 
preparation purified by 1 cycle) was chemically acetylated to obtain 100% AcTubulin. In this 
preparation, tubulin representedapproximately 55% of total proteins (results not shown). Various 
amounts of protein were subjected to Western blotting and visualized for AcTubulin. The bands 
were scanned and optical density values were calculated as a function of protein amount. The 
values are presented as the means ± S.D. from quadruplicate determinations. 
 
Fig. 4. Quantification of AcTubulin in partially purified preparations. An AcTubulin-enriched 
preparation (microtubule protein purified by 1 cycle; 2.5 mg/ml) was mixed in various proportions 
with an AcTubulin-depleted preparation (microtubule protein purified by 1 cycle; 2.5 mg/ml). The 
resulting mixtures consisted of 7.5, 27.5, and 60% AcTubulin. Aliquots of each preparation (100 µl) 
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were used to determine AcTubulin content by our quantification method (see Materials and 
Methods). The values shown are the means ± S.D. from 3 independent experiments. 
 
Fig. 5. Quantification of AcTubulin in cultured cells. (A) Effects of the presence of the 
detergents SDS and Triton X-100 on chemical acetylation. Aliquots of a soluble tubulin preparation 
(SN1, obtained in the absence of TSA), after the addition of SDS or Triton X-100 (final 
concentration 0%, 1%, or 3% in both cases) were chemically acetylated and subjected to Western 
blotting and subsequent staining for AcTubulin (AcTub). (B) CHO, COS, and CAD cells were 
cultured in 10-mm dishes and treated with (+TSA) or without (-TSA) 5 µM TSA for 6 h, and the 
AcTubulin content was measured as described in Materials and Methods. The values shown are 
the means ± S.D. from 4 independent experiments. (C) The same cell types as in (B) were grown 
on coverslips and processed in the same way (+TSA or -TSA; 6 h), and acetylated microtubules 
were visualized by immunofluorescence. Scale bar = 20 µm. 
 
Fig. 6. Quantification of AcTubulin in CHO and COS cells before and after taxol treatment. 
(A) Cells were grown on coverslips and treated with 5 µM taxol for 0, 2, or 6 h, and microtubules 
were visualized by immunofluorescence microscopy using anti-AcTubulin mAb 6-11B-1. Scale bar 
= 20 µm. (B) Cells were grown in 10-cm dishes and treated as in (A) in parallel experiments. The 
AcTubulin content was measured by the chemical acetylation method as described in Materials 
and Methods. The values shown are the means ± S.D. from 3 independent experiments. 
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